{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T03:47:12Z","timestamp":1782532032139,"version":"3.54.5"},"reference-count":30,"publisher":"Japanese Circulation Society","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Circ J"],"published-print":{"date-parts":[[2026,6,25]]},"DOI":"10.1253\/circj.cj-25-0869","type":"journal-article","created":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T22:09:05Z","timestamp":1775772545000},"page":"795-804","source":"Crossref","is-referenced-by-count":1,"title":["Contribution of Non-Sustained Ventricular Tachycardia to the Primary Prevention of Sudden Cardiac Death\u3000\u2015 Validation of Current Japanese Circulation Society \/ Japanese Heart Rhythm Society Guideline Recommendations in the Nippon Storm Study \u2015"],"prefix":"10.1253","volume":"90","author":[{"given":"Ryobun","family":"Yasuoka","sequence":"first","affiliation":[{"name":"Division of Cardiology, Kindai University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Maruyama","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Kindai University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Noda","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Kindai University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaku","family":"Nakazawa","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Kindai University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Nitta","sequence":"additional","affiliation":[{"name":"Nippon Medical School"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshifusa","family":"Aizawa","sequence":"additional","affiliation":[{"name":"Department of Research and Development, Tachikawa Medical Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tohru","family":"Ohe","sequence":"additional","affiliation":[{"name":"Okayama City Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Kurita","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Kindai University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Nippon Storm Investigators","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"330","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. <i>N Engl J Med<\/i> 2002; 346: 877\u2013883.","DOI":"10.1056\/NEJMoa013474"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. <i>N Engl J Med<\/i> 2005; 352: 225\u2013237.","DOI":"10.1056\/NEJMoa043399"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. K\u00f8ber L, Thune JJ, Nielsen JC, Haarbo J, Videb\u00e6k L, Korup E, et al. Defibrillator implantation in patients with nonischemic systolic heart failure. <i>N Engl J Med<\/i> 2016; 375: 1221\u20131230.","DOI":"10.1056\/NEJMoa1608029"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Zabel M, Willems R, Lubinski A, Bauer A, Brugada J, Conen D, et al. Clinical effectiveness of primary prevention implantable cardioverter-defibrillators: Results of the EU-CERT-ICD controlled multicentre cohort study. <i>Eur Heart J<\/i> 2020; 41: 3437\u20133447.","DOI":"10.1093\/eurheartj\/ehaa226"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Buxton AE, Lee KL, Fisher JD, Josephson ME, Prystowsky EN, Hafley G. A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators. <i>N Engl J Med<\/i> 1999; 341: 1882\u20131890.","DOI":"10.1056\/NEJM199912163412503"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Kadish A, Dyer A, Daubert JP, Quigg R, Estes NA, Anderson KP, et al. Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. <i>N Engl J Med<\/i> 2004; 350: 2151\u20132158.","DOI":"10.1056\/NEJMoa033088"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Al-Khatib SM, Stevenson WG, Ackerman MJ, Bryant WJ, Callans DJ, Curtis AB, et al. 2017 AHA\/ACC\/HRS Guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: A report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. <i>Circulation<\/i> 2018; 138: e272\u2013e391.","DOI":"10.1161\/CIR.0000000000000614"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Zeppenfeld K, Tfelt-Hansen J, de Riva M, Winkel BG, Behr ER, Blom NA, et al. 2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. <i>Eur Heart J<\/i> 2022; 43: 3997\u20134126.","DOI":"10.1093\/eurheartj\/ehac699"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Nogami A, Kurita T, Abe H, Ando K, Ishikawa T, Imai K, et al. JCS\/JHRS 2019 Guideline on non-pharmacotherapy of cardiac arrhythmias. <i>Circ J<\/i> 2021; 85: 1104\u20131244.","DOI":"10.1253\/circj.CJ-20-0637"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Aonuma K, Ando K, Kusano K, Asai T, Inoue K, Inamura Y, et al. Primary results from the Japanese Heart Failure and Sudden Cardiac Death Prevention Trial (HINODE). <i>ESC Heart Fail<\/i> 2022; 9: 1584\u20131596.","DOI":"10.1002\/ehf2.13901"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Bigger JT Jr, Fleiss JL, Kleiger R, Miller JP, Rolnitzky LM. The relationships among ventricular arrhythmias, left ventricular dysfunction, and mortality in the 2 years after myocardial infarction. <i>Circulation<\/i> 1984; 69: 250\u2013258.","DOI":"10.1161\/01.CIR.69.2.250"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Buxton AE, Marchlinski FE, Waxman HL, Flores BT, Cassidy DM, Josephson ME. Prognostic factors in nonsustained ventricular tachycardia. <i>Am J Cardiol<\/i> 1984; 53: 1275\u20131279.","DOI":"10.1016\/0002-9149(84)90078-X"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Doval HC, Nul DR, Grancelli HO, Varini SD, Soifer S, Corrado G, et al. Nonsustained ventricular tachycardia in severe heart failure. Independent marker of increased mortality due to sudden death. GESICA-GEMA Investigators. <i>Circulation<\/i> 1996; 94: 3198\u20133203.","DOI":"10.1161\/01.CIR.94.12.3198"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Singh SN, Fisher SG, Carson PE, Fletcher RD. Prevalence and significance of nonsustained ventricular tachycardia in patients with premature ventricular contractions and heart failure treated with vasodilator therapy. Department of Veterans Affairs CHF STAT Investigators. <i>J Am Coll Cardiol<\/i> 1998; 32: 942\u2013947.","DOI":"10.1016\/S0735-1097(98)00338-6"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Teerlink JR, Jalaluddin M, Anderson S, Kukin ML, Eichhorn EJ, Francis G, et al. Ambulatory ventricular arrhythmias in patients with heart failure do not specifically predict an increased risk of sudden death (Prospective Randomized Milrinone Survival Evaluation). <i>Circulation<\/i> 2000; 101: 40\u201346.","DOI":"10.1161\/01.CIR.101.1.40"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Satake H, Fukuda K, Sakata Y, Miyata S, Nakano M, Kondo M, et al. Current status of primary prevention of sudden cardiac death with implantable cardioverter defibrillator in patients with chronic heart failure: A report from the CHART-2 Study. <i>Circ J<\/i> 2015; 79: 381\u2013390.","DOI":"10.1253\/circj.CJ-14-0925"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Yokoshiki H, Shimizu A, Mitsuhashi T, Furushima H, Sekiguchi Y, Manaka T, et al. Prognostic significance of nonsustained ventricular tachycardia in patients receiving cardiac resynchronization therapy for primary prevention: Analysis of the Japan Cardiac Device Treatment Registry database. <i>J Arrhythm<\/i> 2018; 34: 139\u2013147.","DOI":"10.1002\/joa3.12023"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Noda T, Kurita T, Nitta T, Chiba Y, Furushima H, Matsumoto N, et al. Significant impact of electrical storm on mortality in patients with structural heart disease and an implantable cardiac defibrillator. <i>Int J Cardiol<\/i> 2018; 255: 85\u201391.","DOI":"10.1016\/j.ijcard.2017.11.077"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Kuroda S, Kawamura I, Sahashi Y, Kuno T. The significance of non-sustained ventricular tachycardia on life-threatening ventricular arrhythmia events in patients with non-ischemic cardiomyopathy in the contemporary era: A systematic review and meta-analysis. <i>J Cardiol<\/i> 2024; 84: 177\u2013179.","DOI":"10.1016\/j.jjcc.2024.05.004"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. de Sousa MR, Morillo CA, Rabelo FT, Nogueira Filho AM, Ribeiro AL. Non-sustained ventricular tachycardia as a predictor of sudden cardiac death in patients with left ventricular dysfunction: A meta-analysis. <i>Eur J Heart Fail<\/i> 2008; 10: 1007\u20131014.","DOI":"10.1016\/j.ejheart.2008.07.002"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Ishibashi K, Oka S, Nakamura T, Miyazaki Y, Wakamiya A, Ueda N, et al. Implications of non-sustained ventricular tachycardia in the indication for primary prevention with an implantable cardioverter defibrillator: Subanalysis from the Japanese Heart Failure and Sudden Cardiac Death Prevention Trial (HINODE). <i>Circ J<\/i> 2025; 90: 88\u201395.","DOI":"10.1253\/circj.CJ-24-0888"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Makimoto H, Zielke S, Clasen L, Lin T, Gerguri S, M\u00fcller P, et al. Clinical significance of precedent asymptomatic non-sustained ventricular tachycardias on subsequent ICD interventions and heart failure hospitalization in primary prevention ICD patients. <i>Eur J Med Res<\/i> 2020; 25: 5.","DOI":"10.1186\/s40001-020-0401-x"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Sato H, Noda T, Ito T, Yamamoto N, Chiba T, Hasebe Y, et al. Optimizing patient selection for cardiac resynchronization therapy with or without defibrillator in a multicenter study of Japanese patients: Assessment of the MADIT-ICD benefit score. <i>Circ J<\/i> 2025; 89: 224\u2013233.","DOI":"10.1253\/circj.CJ-24-0329"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Kondo Y, Chiba T, Kobayashi Y. Prognostic value of non-sustained ventricular tachycardia for sudden cardiac death: Clinical implications and outcomes. <i>Circ J<\/i> 2025; 90: 96\u201398.","DOI":"10.1253\/circj.CJ-25-0690"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Komatsu Y, Hocini M, Nogami A, Maury P, Peichl P, Iwasaki YK, et al. Catheter ablation of refractory ventricular fibrillation storm after myocardial infarction. <i>Circulation<\/i> 2019; 139: 2315\u20132325.","DOI":"10.1161\/CIRCULATIONAHA.118.037997"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Iwasaki YK, Noda T, Akao M, Fujino T, Hirano T, Inoue K, et al. JCS\/JHRS 2024 Guideline focused update on management of cardiac arrhythmias. <i>Circ J<\/i> 2025; 89: 1012\u20131073.","DOI":"10.1253\/circj.CJ-24-0073"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Schuger C, Joung B, Ando K, Mont L, Lambiase PD, O\u2019Hara GE, et al. Assessment of antitachycardia pacing in primary prevention patients: The APPRAISE ATP randomized clinical trial. <i>JAMA<\/i> 2024; 332: 1723\u20131731.","DOI":"10.1001\/jama.2024.16531"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. M\u00e4kikallio TH, Barthel P, Schneider R, Bauer A, Tapanainen JM, Tulppo MP, et al. Prediction of sudden cardiac death after acute myocardial infarction: Role of Holter monitoring in the modern treatment era. <i>Eur Heart J<\/i> 2005; 26: 762\u2013769.","DOI":"10.1093\/eurheartj\/ehi188"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Zecchin M, Di Lenarda A, Gregori D, Merlo M, Pivetta A, Vitrella G, et al. Are nonsustained ventricular tachycardias predictive of major arrhythmias in patients with dilated cardiomyopathy on optimal medical treatment? <i>Pacing Clin Electrophysiol<\/i> 2008; 31: 290\u2013299.","DOI":"10.1111\/j.1540-8159.2008.00988.x"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Ruwald MH, Ruwald AC, Johansen JB, Gislason G, Lindhardt TB, Nielsen JC, et al. Temporal incidence of appropriate and inappropriate therapy and mortality in secondary prevention ICD patients by cardiac diagnosis. <i>JACC Clin Electrophysiol<\/i> 2021; 7: 781\u2013792.","DOI":"10.1016\/j.jacep.2020.11.005"}],"container-title":["Circulation Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/90\/7\/90_CJ-25-0869\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T03:23:41Z","timestamp":1782530621000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/90\/7\/90_CJ-25-0869\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,25]]},"references-count":30,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1253\/circj.cj-25-0869","relation":{},"ISSN":["1346-9843","1347-4820"],"issn-type":[{"value":"1346-9843","type":"print"},{"value":"1347-4820","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,25]]},"article-number":"CJ-25-0869"}}